Table IV.
Proportion of study participants meeting various criteria for Lund-Mackay (L-M) scores by subject characteristics, in study sample (unweighted) and estimated in source population (native weights)
| Characteristic | N (%) | Study Sample (n = 646) Unweighted Percent (SE) |
Source Population Weighted† Percent (SE) |
||||
|---|---|---|---|---|---|---|---|
| L-M ≥ 3 | L-M ≥ 4 | L-M ≥ 6 | L-M ≥ 3 | L-M ≥ 4 | L-M ≥ 6 | ||
| Sex | |||||||
| Female | 431 (66.7) | 20.7 (2.0)* | 15.7 (1.8)* | 10.7 (1.5)** | 11.1 (3.0) | 9.9 (3.0) | 5.7 (2.3) |
| Male | 215 (33.3) | 36.7 (3.3) | 32.1 (3.2) | 20.0 (2.7) | 16.1 (5.0) | 14.6 (4.7) | 8.7 (3.6) |
| Age, years | |||||||
| 18–39 | 57 (8.8) | 26.3 (5.8) | 21.1 (5.4) | 19.3 (5.2) | 25.5 (9.9) | 22.0 (9.5) | 21.8 (9.4)** |
| 40–49 | 111 (17.2) | 19.8 (3.8) | 15.3 (3.4) | 9.9 (2.8) | 2.3 (1.2) | 2.1 (1.1) | 1.5 (0.9) |
| 50–59 | 184 (28.5) | 27.7 (3.3) | 22.3 (3.1) | 12.0 (2.4) | 17.2 (7.8) | 15.7 (7.6) | 3.9 (2.0) |
| 60–69 | 190 (29.4) | 24.7 (3.1) | 21.6 (3.0) | 14.2 (2.5) | 14.7 (6.0) | 14.4 (6.0) | 11.5 (5.5) |
| 70+ | 104 (16.1) | 31.7 (4.6) | 25.0 (4.2) | 17.3 (3.7) | 10.2 (4.6) | 6.8 (3.0) | 2.6 (1.4) |
| Race/ethnicity | |||||||
| Non-Hispanic white | 620 (96.0) | 26.3 (1.8) | 21.3 (1.6) | 13.7 (1.4) | 11.8 (2.3) | 10.5 (2.2) | 5.7 (1.7) |
| Non-white | 26 (4.0) | 19.2 (7.7) | 19.2 (7.7) | 15.4 (7.1) | 28.6 (21.5) | 28.6 (21.5) | 27.8 (21.5) |
| Migraine headache‡ | |||||||
| Yes | 229 (35.4) | 22.3 (2.8) | 15.7 (2.4)* | 9.2 (1.9)** | 9.6 (4.0) | 8.0 (3.5) | 4.3 (2.3) |
| No | 417 (64.6) | 28.1 (2.2) | 24.2 (2.1) | 16.3 (1.8) | 13.2 (3.0) | 12.0 (3.0) | 7.2 (2.4) |
| CRSS status§ | |||||||
| Current | 324 (50.2) | 27.5 (2.5) | 22.5 (2.3) | 12.7 (1.8) | 22.5 (4.7)** | 19.7 (4.6) | 8.0 (4.1) |
| Past | 249 (38.5) | 25.3 (2.8) | 20.5 (2.6) | 14.9 (2.3) | 16.2 (3.2) | 13.8 (2.9) | 8.7 (2.5) |
| Never | 73 (11.3) | 21.9 (4.8) | 17.8 (4.5) | 15.1 (4.2) | 8.1 (3.4) | 7.8 (3.4) | 5.3 (2.7) |
| Anxiety sensitivity index¶ | |||||||
| High | 309 (47.8) | 27.5 (2.5) | 19.6 (2.2) | 14.6 (2.0) | 21.1 (7.3)3 | 19.7 (7.1)* | 11.3 (5.4) |
| Low | 337 (52.2) | 24.6 (2.3) | 23.0 (2.4) | 13.1 (1.8) | 8.5 (1.7) | 7.4 (1.6) | 4.4 (1.4) |
| Asthma, self-reported physician diagnosis, ever | |||||||
| Yes | 197 (30.5) | 33.0 (3.4)** | 27.4 (3.2)** | 19.8 (2.8)** | 28.1 (8.8)** | 22.8 (8.5)** | 11.2 (3.5) |
| No | 449 (69.5) | 22.9 (2.0) | 18.5 (1.8) | 11.1 (1.5) | 9.6 (2.2) | 9.1 (2.2) | 5.7 (2.1) |
| Prior sinus surgery¥ | |||||||
| Yes | 120 (18.6) | 50.8 (4.6)* | 41.7 (4.5)* | 29.2 (4.2)* | 56.0 (7.4)* | 53.2 (7.7)* | 31.3 (12.6)* |
| No | 526 (81.4 | 20.3 (1.8) | 16.5 (1.6) | 10.3 (1.3) | 10.1 (2.3) | 9.1 (2.3) | 5.3 (1.8) |
| TOTAL | 646 (100.0) | 26.01 (1.7) | 21.2 (1.6) | 13.8 (1.4) | 12.4 (2.3) | 11.2 (2.3) | 6.6 (1.9) |
†
Weighted for sampling and participation rates back to source population.
*
p < 0.0001
**
p < 0.05
‡
Based on questions from the ID Migraine Questionnaire.
§
Never: did not report European Position Paper on Rhinosinusitis (EPOS) CRS symptoms in lifetime; past: met EPOS CRS symptoms in lifetime but not currently; current: met EPOS CRS symptoms in the last 3 months.
¶
Divided at the median: high = at/above median; low = less than the median.
¥
Evidence of sinus surgery on sinus CT.